Litcius/Paper detail

Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma

Jing‐Jun Nie, Yanli Liu, Qi Yu, Nasha Zhang, Bingran Yu, Dafu Chen, Ming Yang, Fu‐Jian Xu

2021Journal of Controlled Release33 citationsDOI

Topics & Concepts

Hepatocellular carcinomaCRISPRCancer researchOncogeneSorafenibCas9SurvivinApoptosisDelivery systemCancerMedicineAngiogenesisTargeted therapyLiver cancerBiologyPharmacologyInternal medicineBiochemistryCell cycleGeneCRISPR and Genetic EngineeringAdvanced biosensing and bioanalysis techniquesRNA Interference and Gene Delivery
Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma | Litcius